Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection

Diseases of the Colon and Rectum

Volumn 52, Issue 4, 2009, Pages 669-677

  Yau, Thomas ^a   Watkins, David ^a   Cunningham, David ^a,b   Barbachano, Yolanda ^a   Chau, Ian ^a   Chong, Geoffrey ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Quality of life; Rectal cancer; Social functioning; Stoma

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVOR; COLORECTAL CANCER; COLOSTOMY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM RESECTION; SCORING SYSTEM; SOCIAL INTERACTION; STOMA; SYMPTOMATOLOGY; TREATMENT DURATION; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLOSTOMY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RECTAL NEOPLASMS;

EID: 66849138074     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31819eb970     Document Type: Article

References (21)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638Y46.
2. Fernandez-Martos C, Aparicio J, Bosch C, et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-up. J Clin Oncol 2004;22:3016Y22.
3. Feliu J, Calvilio J, Escribano A, et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 2002;13:730Y6.
4. Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;2:1812Y3.
5. Enker WE, Havenga K, Polyak T, Thaler H, Cranor M. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer. World J Surg 1997;21:715Y20.
6. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2004;(3):CD004323.
7. Grundmann R, Said S, Krinke S. Quality of life after rectal resection or extirpation: a comparison using different measurement parameters [in German]. Dtsch MedWochenschr 1989; 114:453Y7.
8. Kuzu MA, Topcu O, Ucar K, et al. Effect of sphinctersacrificing surgery for rectal carcinoma on quality of life in Muslim patients. Dis Colon Rectum 2002;45:1359Y66.
9. Marquis R, Lasry JC, Heppell J, Potvin C, Falardeau M, Robidoux A. Quality of life of patients after restorative surgery for cancer of the rectum [in French]. Ann Chir 1992;46: 830Y8.
10. Allal AS, Bieri S, Pelloni A, et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes. Br J Cancer 2000;82:1131Y7.
11. Camilleri-Brennan J, Steele RJ. Objective assessment of morbidity and quality of life after surgery for low rectal cancer. Colorectal Dis 2002;4:61Y6.
12. Grumann MM, Noack EM, Hoffmann IA, Schlag PM. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001;233:149Y56.
13. Hamashima C. Long-term quality of life of postoperative rectal cancer patients. J Gastroenterol Hepatol 2002;17:571Y6.
14. Jess P, Christiansen J, Bech P. Quality of life after anterior resection versus abdominoperineal extirpation for rectal cancer. Scand J Gastroenterol 2002;37:1201Y4.
15. Saini A, Norman AR, Cunningham D, et al. Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. Br J Cancer 2003;88:1859Y65.
16. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365Y76.
17. Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 2003;238:203Y13.
18. Rauch P, Miny J, Conroy T, Neyton L, Guillemin F. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004;22:354Y60.
19. Whynes DK, Neilson AR, Robinson MH, Hardcastle JD. Colorectal cancer screening and quality of life. Qual Life Res 1994;3:191Y8.
20. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139Y44.
21. Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 1999;35:238Y47.